INCR

Intercure Ltd. Ordinary Shares

3.47

USD

+0.18

+5.31%

Nov 06, 15:59 UTC -5

Closed

After-Market

3.49

+0.02

+0.58%

Intercure Ltd. Ordinary Shares (INCR) Earnings

INCR Earnings Reports

Positive Surprise Ratio

INCR beat 3 of 8 last estimates.

38%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q2 26 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Intercure Ltd. Ordinary Shares earnings per share and revenue

On Oct 06, 2026, INCR reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Canopy Growth Corporation Common Shares

Report Date

Nov 06, 2026 For Q2 27

Estimate

-$0.03

Actual

-$0.01

Surprise

+71.75%

InfuSystem Holdings, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.13

Actual

$0.15

Surprise

+13.12%

Aurora Cannabis Inc. Common Shares

Report Date

Nov 05, 2026 For Q2 27

Estimate

-$0.08

Actual

-$0.32

Surprise

-261.99%

Apyx Medical Corporation Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.09

Actual

-$0.04

Surprise

+57.98%

Lantheus Holdings, Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.26

Actual

$1.68

Surprise

+32.47%

Haemonetics Corporation

Report Date

Nov 05, 2026 For Q2 27

Estimate

$1.30

Actual

$1.35

Surprise

+3.53%

ICU Medical Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

$2.17

Actual

$2.44

Surprise

+11.93%

Prestige Consumer Healthcare Inc.

Report Date

Nov 05, 2026 For Q2 27

Estimate

$1.08

Actual

$1.12

Surprise

+4.28%

Trulieve Cannabis Corp.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.07

Actual

$0.00

Surprise

-100.00%

Nephros Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.02

Actual

$0.05

Surprise

+110.08%

FAQ

What were Intercure Ltd. Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Intercure Ltd. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Intercure Ltd. Ordinary Shares's Q2 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Intercure Ltd. Ordinary Shares expected to report next?

The next earning report is scheduled for --.

What are the forecasts for Intercure Ltd. Ordinary Shares's next earnings report?

Based on -- analysts, Intercure Ltd. Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.